183 related articles for article (PubMed ID: 7583916)
1. Intrinsic defect in B cells of patients with hyper-immunoglobulin M syndrome.
Porat YB; Levy D; Levy J; Zan-Bar I
Clin Diagn Lab Immunol; 1995 Jul; 2(4):412-6. PubMed ID: 7583916
[TBL] [Abstract][Full Text] [Related]
2. A transcriptional defect underlies B lymphocyte dysfunction in a patient diagnosed with non-X-linked hyper-IgM syndrome.
Bhushan A; Barnhart B; Shone S; Song C; Covey LR
J Immunol; 2000 Mar; 164(6):2871-80. PubMed ID: 10706672
[TBL] [Abstract][Full Text] [Related]
3. Induction by anti-CD40 antibody or soluble CD40 ligand and cytokines of IgG, IgA and IgE production by B cells from patients with X-linked hyper IgM syndrome.
Durandy A; Schiff C; Bonnefoy JY; Forveille M; Rousset F; Mazzei G; Milili M; Fischer A
Eur J Immunol; 1993 Sep; 23(9):2294-9. PubMed ID: 7690328
[TBL] [Abstract][Full Text] [Related]
4. Signaling through CD40 rescues IgE but not IgG or IgA secretion in X-linked immunodeficiency with hyper-IgM.
Saiki O; Tanaka T; Wada Y; Uda H; Inoue A; Katada Y; Izeki M; Iwata M; Nunoi H; Matsuda I
J Clin Invest; 1995 Feb; 95(2):510-4. PubMed ID: 7532185
[TBL] [Abstract][Full Text] [Related]
5. CD40 ligand/CD40 deficiency.
Castigli E; Fuleihan R; Ramesh N; Tsitsikov E; Tsytsykova A; Geha RS
Int Arch Allergy Immunol; 1995; 107(1-3):37-9. PubMed ID: 7542090
[TBL] [Abstract][Full Text] [Related]
6. Pairs of surface molecules involved in human IgE regulation: CD23-CD21 and CD40-CD40L.
Bonnefoy JY; Gauchat JF; Life P; Graber P; Mazzei G; Aubry JP
Eur Respir J Suppl; 1996 Aug; 22():63s-66s. PubMed ID: 8871046
[TBL] [Abstract][Full Text] [Related]
7. IgM- and IgD-bearing peripheral blood lymphocytes differentiate to IgM but not IgG or IgA immunoglobulin-secreting cells.
Saiki O; Ralph P
Eur J Immunol; 1982 Jun; 12(6):506-10. PubMed ID: 6981514
[TBL] [Abstract][Full Text] [Related]
8. CD40 ligand (CD40L) expression and B cell function in agammaglobulinemia with normal or elevated levels of IgM (HIM). Comparison of X-linked, autosomal recessive, and non-X-linked forms of the disease, and obligate carriers.
Callard RE; Smith SH; Herbert J; Morgan G; Padayachee M; Lederman S; Chess L; Kroczek RA; Fanslow WC; Armitage RJ
J Immunol; 1994 Oct; 153(7):3295-306. PubMed ID: 7916370
[TBL] [Abstract][Full Text] [Related]
9. Defective expression of CD40 ligand on T cells causes "X-linked immunodeficiency with hyper-IgM (HIGM1)".
Kroczek RA; Graf D; Brugnoni D; Giliani S; Korthüer U; Ugazio A; Senger G; Mages HW; Villa A; Notarangelo LD
Immunol Rev; 1994 Apr; 138():39-59. PubMed ID: 7915248
[TBL] [Abstract][Full Text] [Related]
10. Repair of immunoglobulin response in B cell line (JK32.1) originating from immunodeficient patient via implantation of functional plasma membranes.
Ben-Anat Porat Y; Zan-Bar I
Clin Immunol Immunopathol; 1995 Feb; 74(2):151-5. PubMed ID: 7828369
[TBL] [Abstract][Full Text] [Related]
11. Diminished expression of CD40 ligand by activated neonatal T cells.
Nonoyama S; Penix LA; Edwards CP; Lewis DB; Ito S; Aruffo A; Wilson CB; Ochs HD
J Clin Invest; 1995 Jan; 95(1):66-75. PubMed ID: 7814647
[TBL] [Abstract][Full Text] [Related]
12. Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome.
Agematsu K; Nagumo H; Shinozaki K; Hokibara S; Yasui K; Terada K; Kawamura N; Toba T; Nonoyama S; Ochs HD; Komiyama A
J Clin Invest; 1998 Aug; 102(4):853-60. PubMed ID: 9710455
[TBL] [Abstract][Full Text] [Related]
13. Hyper IgM syndrome associated with defective CD40-mediated B cell activation.
Conley ME; Larché M; Bonagura VR; Lawton AR; Buckley RH; Fu SM; Coustan-Smith E; Herrod HG; Campana D
J Clin Invest; 1994 Oct; 94(4):1404-9. PubMed ID: 7523449
[TBL] [Abstract][Full Text] [Related]
14. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination.
Imai K; Catalan N; Plebani A; Maródi L; Sanal O; Kumaki S; Nagendran V; Wood P; Glastre C; Sarrot-Reynauld F; Hermine O; Forveille M; Revy P; Fischer A; Durandy A
J Clin Invest; 2003 Jul; 112(1):136-42. PubMed ID: 12840068
[TBL] [Abstract][Full Text] [Related]
15. Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expression.
Durandy A; Hivroz C; Mazerolles F; Schiff C; Bernard F; Jouanguy E; Revy P; DiSanto JP; Gauchat JF; Bonnefoy JY; Casanova JL; Fischer A
J Immunol; 1997 Mar; 158(6):2576-84. PubMed ID: 9058789
[TBL] [Abstract][Full Text] [Related]
16. T cell clones from an X-linked hyper-immunoglobulin (IgM) patient induce IgE synthesis in vitro despite expression of nonfunctional CD40 ligand.
Life P; Gauchat JF; Schnuriger V; Estoppey S; Mazzei G; Durandy A; Fischer A; Bonnefoy JY
J Exp Med; 1994 Nov; 180(5):1775-84. PubMed ID: 7964460
[TBL] [Abstract][Full Text] [Related]
17. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM.
Korthäuer U; Graf D; Mages HW; Brière F; Padayachee M; Malcolm S; Ugazio AG; Notarangelo LD; Levinsky RJ; Kroczek RA
Nature; 1993 Feb; 361(6412):539-41. PubMed ID: 7679206
[TBL] [Abstract][Full Text] [Related]
18. Somatic mutations in human Ig variable genes correlate with a partially functional CD40-ligand in the X-linked hyper-IgM syndrome.
Razanajaona D; van Kooten C; Lebecque S; Bridon JM; Ho S; Smith S; Callard R; Banchereau J; Brière F
J Immunol; 1996 Aug; 157(4):1492-8. PubMed ID: 8759730
[TBL] [Abstract][Full Text] [Related]
19. Induction of human immunoglobulin secretion. I. Synergistic effect of B cell mitogen Cowan I plus T cell mitogens or factors.
Saiki O; Ralph P
J Immunol; 1981 Sep; 127(3):1044-7. PubMed ID: 6973576
[TBL] [Abstract][Full Text] [Related]
20. CD40 ligand and its role in X-linked hyper-IgM syndrome.
Callard RE; Armitage RJ; Fanslow WC; Spriggs MK
Immunol Today; 1993 Nov; 14(11):559-64. PubMed ID: 7506037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
